Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/23/2010US20100324100 Sustained release aminopyridine compositions
12/23/2010US20100324099 Sustained release aminopyridine compositions
12/23/2010US20100324098 Sustained release aminopyridine compositions
12/23/2010US20100324097 Method of Providing Pirfenidone Therapy to a Patient
12/23/2010US20100324095 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
12/23/2010US20100324094 Conformationally Restrained Epothilone Analogues as Anti-Leukemic Agents
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324092 Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
12/23/2010US20100324091 Pyrazolone Derivative
12/23/2010US20100324090 Compositions of tolperisone
12/23/2010US20100324089 Anti-inflammatory composition
12/23/2010US20100324088 Fused Pyridone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324087 Combined use of angiogenesis inhibitor and taxane
12/23/2010US20100324086 Compounds and methods
12/23/2010US20100324085 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
12/23/2010US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application
12/23/2010US20100324083 Combinations of Organic Compounds
12/23/2010US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/23/2010US20100324081 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient
12/23/2010US20100324080 Benzomorphan Compounds
12/23/2010US20100324079 Medicament for prophylaxis and treatment of Alzheimer disease
12/23/2010US20100324078 Crystalline Forms of Naltrexone Methobromide
12/23/2010US20100324076 Novel sEH Inhibitors and their Use
12/23/2010US20100324075 Therapeutic use of carboxyl ester lipase inhibitors
12/23/2010US20100324074 Protein Kinase Inhibitors
12/23/2010US20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds
12/23/2010US20100324072 Pyrrolopyridine derivatives and their use as bace inhibitors
12/23/2010US20100324071 Novel glucokinase activators and methods of using same
12/23/2010US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324069 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324068 Chemical compounds 785
12/23/2010US20100324067 Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities
12/23/2010US20100324066 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same
12/23/2010US20100324065 Compounds and methods for development of Ret Modulators
12/23/2010US20100324064 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
12/23/2010US20100324063 Jak2 tyrosine kinase inhibition
12/23/2010US20100324062 Compounds and compositions as protein kinase inhibitors
12/23/2010US20100324061 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
12/23/2010US20100324060 Pharmaceutical compositions useful for treating hcv
12/23/2010US20100324059 Pharmaceutical compositions useful for treating hcv
12/23/2010US20100324058 thrombin function compounds and pharmaceutical compositions based on them
12/23/2010US20100324057 Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient
12/23/2010US20100324056 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324055 Solid states forms of varenicline salts and processes for preparation thereof
12/23/2010US20100324054 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/23/2010US20100324053 Trisubstituted 1,2,4 triazoles
12/23/2010US20100324052 Novel piperidine carboxylic acid amine derivatives
12/23/2010US20100324051 Novel compounds as opioid receptor modulators
12/23/2010US20100324050 Inhibitors of bruton's tyrosine kinase
12/23/2010US20100324049 Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptor
12/23/2010US20100324048 Disubstituted phthalazine hedgehog pathway antagonists
12/23/2010US20100324047 Raf kinase modulators and methods of use
12/23/2010US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/23/2010US20100324045 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/23/2010US20100324044 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324042 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/23/2010US20100324041 Pyrrolopyridines as kinase inhibitors
12/23/2010US20100324040 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyrazol-3-yl) -3h-imidazo[4,5-b] pyridin-5- amine derivatives and their use for the treatment of cancer
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324038 Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
12/23/2010US20100324037 Pharmacokinetically improved compounds
12/23/2010US20100324036 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
12/23/2010US20100324035 Carboxamide Compounds and Their Use
12/23/2010US20100324034 Methods of Using SAHA for Treating HIV Infection
12/23/2010US20100324033 Oxadiazoanthracene compounds for the treatment of diabetes
12/23/2010US20100324032 Compounds and uses thereof in modulating amyloid beta
12/23/2010US20100324031 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100324028 Novel compounds
12/23/2010US20100324027 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100324024 Quinolizidinone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324023 Imidazobenzazepine cgrp receptor antagonists
12/23/2010US20100324022 Novel compounds
12/23/2010US20100324021 (dihydro)imidazoiso[5,1-a]quinolines
12/23/2010US20100324020 Bicyclic [3.1.0] Heteroaryl Amides As Type 1 Glycine Transport Inhibitors
12/23/2010US20100324019 Use of Riboflavin in the Treatment of Hypertension
12/23/2010US20100324018 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324014 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324013 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324012 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324011 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324010 Amide compounds and use of the same
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100324008 Psma binding ligand-linker conjugates and methods for using
12/23/2010US20100324007 Oral suspension of prednisolone acetate
12/23/2010US20100324006 Hormone delivery system and method
12/23/2010US20100324005 Method for treatment of diseases
12/23/2010US20100324004 Method for Treating Diabetes
12/23/2010US20100324003 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
12/23/2010US20100324002 Inhaled combination therapy
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
1 ... 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 ... 7860